Question 1

What is ImmunoPrecise Antibodies Ltd. (HYFT) stock price today?

Accepted Answer

ImmunoPrecise Antibodies Ltd. (HYFT) currently trades at $1.19 per share. The stock has a market capitalization of $54.19M and a P/E ratio of —x.

Question 2

Is HYFT stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, ImmunoPrecise Antibodies Ltd. has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is ImmunoPrecise Antibodies Ltd.'s revenue and earnings?

Accepted Answer

ImmunoPrecise Antibodies Ltd. has trailing twelve-month (TTM) revenue of $28.08M with profit margins of -43.60%. Earnings per share (EPS) is $-0.10.

Question 4

Is HYFT stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, ImmunoPrecise Antibodies Ltd.'s intrinsic value is $2.58, representing a margin of safety of 42.25%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$19.80M	$21.17M	$24.81M	$24.31M	$28.08M
Net income	$-17.09M	$-27.21M	$-26.43M	$-29.97M	$-3.87M
EPS	—	—	—	—	$-0.10
Free cash flow	$-11.18M	$-21.33M	$-5.64M	$-7.21M	$-2.96M
Profit margin	-86.29%	-128.53%	-106.51%	-123.30%	-43.60%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HYFT	$54.19M	31	6.7	2.0	6.7	5.0	+42.25%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

ImmunoPrecise Antibodies Ltd.

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare